For two decades scientists have been quietly developing self-spreading contagious vaccines. The NIH funded this research, in which either DNA from a deadly pathogen is packaged in a contagious but less harmful virus, or the deadly virus’s lethality is weakened by engineering it in a lab.
The resultant “vaccines” spread from one person to the next just like a contagious respiratory virus. Only five percent of regional populations would need to be immunized; the other ninety-five percent would “catch” the vaccine as it spread person-to-person through community transmission.
This technology bypasses the inconvenience of recalcitrant citizens who may refuse to give consent. Its advocates highlight that a mass vaccination campaign that would ordinarily take months of expensive effort to immunize everyone could be shortened to only a few weeks.